Peter Bøggild

bioMASON, Inc. operates as a biotechnology manufacturing company that serves the building and construction industry. It offers concrete, glass, steel, and wood. The company was founded by Ginger Krieg Dosier in 2012 and is headquartered in Research Triangle Park, NC.

Nykredit Bank A/S (Investment Management) (Nykredit IM) is the investment management division of Nykredit Bank A/S, ultimately held by Forengin Nykredit in Denmark. The firm was founded in 1851 and changed their name to Nykredit in 1985 when Forenede Kreditforeninger and Jyllands Kreditforening merged. Nykredit IM is headquartered in Copenhagen and provides securities management, deposit and loan products, financial instruments and asset management services for individual, corporate and commercial clients.

Hempel A/S manufactures and supplies decorative paints and antifouling products. It is a coatings supplier for the decorative, protective, marine, container and yacht markets. The company was founded in 1915 and is headquartered in Kongens Lyngby, Denmark.

Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark.

Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.

Part of Novo Nordisk A/S, Novo Nordisk Pharma NV develops pharmaceuticals and treatments for people with chronic illness. The company is based in Brussels, Belgium. The CEOs are Mads Lausten, Axel de Muyt. The Belgian company was founded in 1974.

Novo Nordisk Farma Oy provides diabetes care services. The firm also engages in development of haemophilia care, growth hormone therapy and menopausal hormone therapy. The company was founded in 1972 and is headquartered in Espoo, Finland.

Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom.

Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden.

Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland.

Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland.

Part of Novo Nordisk A/S, Novo Nordisk Pharma Operations A/S is a Danish company that engages in the pharmaceutical and medicine manufacturing industry. The company is based in Bagsværd, Denmark. The company was founded in 2009. Lars Bo Smidt has been the CEO of the company since 2020.

Founded in 2016, Novo Nordisk Denmark A/S is a wholesaler of pharmaceutical goods and medical supplies. Part of Novo Nordisk A/S, the company is based in Copenhagen, Denmark.

Part of FLSmidth & Co. A/S, FLSmidth A/S is a Danish company that provides flowsheet technology services. The company is based in Valby, Denmark. The company was founded in 1991 by Ole Falvig Ramsby, Birger Riisager. The CEO is Mikko Juhani Keto.